Next Article in Journal
Understanding the Post-Treatment Concerns of Cancer Survivors with Five Common Cancers: Exploring the Alberta Results from the Pan-Canadian Transitions Study
Previous Article in Journal
5-Fluorouracil/L-Leucovorin Plus Oxaliplatin (FOLFOX) Regimen as Salvage Chemotherapy for Patients with Unresectable Pancreatic Cancer Receiving Gemcitabine and Nab-Paclitaxel and 5-Fluorouracil/L-Leucovorin Plus Nanoliposomal Irinotecan: Preliminary Results from Clinical Practice
 
 
Article

Article Versions Notes

Action Date Notes Link
article xml file uploaded 12 April 2022 06:35 CEST Original file -
article xml uploaded. 12 April 2022 06:35 CEST Update -
article pdf uploaded. 12 April 2022 06:35 CEST Version of Record -
article html file updated 12 April 2022 06:37 CEST Original file -
article xml file uploaded 12 April 2022 07:59 CEST Update -
article xml uploaded. 12 April 2022 07:59 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1718-7729/29/4/217/xml
article pdf uploaded. 12 April 2022 07:59 CEST Updated version of record https://0-www-mdpi-com.brum.beds.ac.uk/1718-7729/29/4/217/pdf
article html file updated 12 April 2022 08:01 CEST Update -
article html file updated 2 August 2022 18:22 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1718-7729/29/4/217/html
Back to TopTop